ReliefWeb·1 min read·medium
Two new candidate vaccines to join Ebola trial as treatment research advances
✦AI Summary
The World Health Organization has recommended adding two new vaccine candidates to the ongoing Tumaini clinical trial in the Democratic Republic of the Congo. This move aims to accelerate research and improve treatment options for Ebola.
Why it matters
Expanding clinical trials for Ebola is critical for global health security and managing potential outbreaks in high-risk regions.
Expert groups convened by the World Health Organization (WHO) have recommended adding two new Ebola vaccine candidates to the ongoing…
Also covering this story
One other newsroom covered this event. We read that version too.
healthscience
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in